Skip to main content
Clinical Trials/NCT00736060
NCT00736060
Completed
N/A

Study the Clinical and Laboratory Characteristics and the Outcome of Sickle Cell Anemia Patients Admitted to the Pediatric Ward Because of Fever as the Presenting Symptom

HaEmek Medical Center, Israel1 site in 1 country60 target enrollmentMay 2008

Overview

Phase
N/A
Intervention
Not specified
Conditions
Sickle Cell Anemia
Sponsor
HaEmek Medical Center, Israel
Enrollment
60
Locations
1
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

This study will summarized the clinical and laboratory data and the outcome of all the patients suffering from Sickle Cell Anemia (Including Sickle cell thalassemia) admitted to the pediatric ward.

Detailed Description

The actual protocol for SCA patients admitted with fever is to obtain blood cultures and start empiric antibiotic treatment. The study cohort included 60 SCA patients actually treated in the Pediatric Hematology Unit.

Registry
clinicaltrials.gov
Start Date
May 2008
End Date
November 2008
Last Updated
14 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dr Koren Ariel

Head of Pediatric Hematology Unit and Pediatric Dpt B

HaEmek Medical Center, Israel

Eligibility Criteria

Inclusion Criteria

  • All patients admitted with fever as the only presenting symptom.

Exclusion Criteria

  • Patients admitted with another causes related or unrelated to sickle cell disease and have also fever.

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials